ID: ALA5279286

Max Phase: Preclinical

Molecular Formula: C20H19Cl2N3

Molecular Weight: 372.30

Associated Items:

Representations

Canonical SMILES:  Nc1nc2cc(N3CCCCC3)ccc2cc1-c1cc(Cl)cc(Cl)c1

Standard InChI:  InChI=1S/C20H19Cl2N3/c21-15-8-14(9-16(22)11-15)18-10-13-4-5-17(12-19(13)24-20(18)23)25-6-2-1-3-7-25/h4-5,8-12H,1-3,6-7H2,(H2,23,24)

Standard InChI Key:  FHBAVYDUKBCGIC-UHFFFAOYSA-N

Associated Targets(non-human)

Leishmania mexicana 936 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

J774.A1 2436 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 372.30Molecular Weight (Monoisotopic): 371.0956AlogP: 5.78#Rotatable Bonds: 2
Polar Surface Area: 42.15Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 7.63CX LogP: 5.71CX LogD: 5.29
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.62Np Likeness Score: -1.07

References

1. Hammill JT, Sviripa VM, Kril LM, Ortiz D, Fargo CM, Kim HS, Chen Y, Rector J, Rice AL, Domagalska MA, Begley KL, Liu C, Rangnekar VM, Dujardin JC, Watt DS, Landfear SM, Guy RK..  (2021)  Amino-Substituted 3-Aryl- and 3-Heteroarylquinolines as Potential Antileishmanial Agents.,  64  (16.0): [PMID:34355566] [10.1021/acs.jmedchem.1c00813]

Source